Prio Wealth Limited Partnership’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$52.5M Sell
84,811
-8,256
-9% -$4.89M 1.54% 17
2024
Q2
$51.5M Sell
93,067
-15,874
-15% -$9.09M 1.53% 16
2024
Q1
$63.3M Sell
108,941
-20,274
-16% -$11.4M 1.83% 13
2023
Q4
$68.6M Buy
129,215
+2,895
+2% +$1.4M 2.36% 7
2023
Q3
$63.9M Sell
126,320
-2,323
-2% -$1.24M 2.46% 8
2023
Q2
$67.1M Sell
128,643
-1,280
-1% -$691K 2.4% 9
2023
Q1
$74.9M Sell
129,923
-10,683
-8% -$6.02M 2.87% 5
2022
Q4
$77.4M Sell
140,606
-4,838
-3% -$2.56M 3.1% 4
2022
Q3
$73.8M Sell
145,444
-4,184
-3% -$2.34M 3.16% 4
2022
Q2
$81.3M Sell
149,628
-14,194
-9% -$7.81M 3.25% 4
2022
Q1
$96.8M Sell
163,822
-5,769
-3% -$3.31M 3.19% 4
2021
Q4
$113M Sell
169,591
-4,397
-3% -$2.75M 3.47% 4
2021
Q3
$99.4M Sell
173,988
-5,069
-3% -$2.78M 3.35% 4
2021
Q2
$90.3M Sell
179,057
-20,823
-10% -$9.82M 3.04% 5
2021
Q1
$91.2M Sell
199,880
-16,228
-8% -$7.75M 3.29% 4
2020
Q4
$101M Sell
216,108
-4,039
-2% -$1.89M 3.78% 3
2020
Q3
$97.2M Sell
220,147
-683
-0.3% -$282K 4.05% 3
2020
Q2
$80M Sell
220,830
-1,752
-0.8% -$587K 3.69% 3
2020
Q1
$63.1M Sell
222,582
-5,250
-2% -$1.66M 3.48% 4
2019
Q4
$74M Buy
227,832
+299
+0.1% +$90.7K 3.14% 3
2019
Q3
$66.3M Sell
227,533
-5,229
-2% -$1.5M 3.03% 3
2019
Q2
$68.4M Sell
232,762
-7,472
-3% -$2.06M 3.14% 3
2019
Q1
$65.8M Sell
240,234
-7,993
-3% -$1.99M 3.08% 4
2018
Q4
$55.5M Sell
248,227
-781
-0.3% -$183K 2.96% 4
2018
Q3
$60.8M Sell
249,008
-2,513
-1% -$578K 2.77% 4
2018
Q2
$52.1M Sell
251,521
-6,941
-3% -$1.47M 2.57% 6
2018
Q1
$53.4M Sell
258,462
-18,603
-7% -$3.9M 2.66% 6
2017
Q4
$52.6M Sell
277,065
-5,221
-2% -$1M 2.46% 8
2017
Q3
$53.4M Sell
282,286
-5,796
-2% -$1.05M 2.61% 6
2017
Q2
$50.3M Sell
288,082
-4,945
-2% -$831K 2.5% 6
2017
Q1
$45M Sell
293,027
-3,273
-1% -$500K 2.31% 7
2016
Q4
$41.8M Sell
296,300
-11,923
-4% -$1.76M 2.23% 7
2016
Q3
$49M Sell
308,223
-5,174
-2% -$797K 2.61% 6
2016
Q2
$46.3M Sell
313,397
-6,179
-2% -$912K 2.54% 6
2016
Q1
$45.2M Sell
319,576
-16,743
-5% -$2.24M 2.47% 6
2015
Q4
$47.7M Sell
336,319
-5,807
-2% -$775K 2.61% 6
2015
Q3
$41.8M Sell
342,126
-31
-0% -$4.04K 2.37% 7
2015
Q2
$44.4M Sell
342,157
-18,652
-5% -$2.43M 2.28% 8
2015
Q1
$48.5M Sell
360,809
-2,212
-0.6% -$285K 2.4% 7
2014
Q4
$45.5M Sell
363,021
-3,690
-1% -$449K 2.27% 7
2014
Q3
$44.6M Sell
366,711
-5,199
-1% -$632K 2.31% 8
2014
Q2
$43.9M Sell
371,910
-13,289
-3% -$1.56M 2.21% 7
2014
Q1
$46.3M Sell
385,199
-23,855
-6% -$2.84M 2.35% 6
2013
Q4
$45.5M Sell
409,054
-519
-0.1% -$51.6K 2.3% 5
2013
Q3
$37.7M Sell
409,573
-15,832
-4% -$1.43M 2.14% 5
2013
Q2
$36M Buy
+425,405
New +$35.4M 2.16% 6

Other funds holding TMO

Prio Wealth Limited Partnership's TMO Position: Q3 2024 in Review

Prio Wealth Limited Partnership reduced its Thermo Fisher Scientific (TMO) stake by 8.9% in Q3 2024, selling an estimated $4.89M and leaving 84,811 shares worth $52.5M. The position accounts for 1.54% of the portfolio, ranked #17.

Prio Wealth Limited Partnership first reported a position in TMO in Q2 2013 and has held it in 46 quarters since. The position peaked at $113M in Q4 2021. 2,568 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

  • Prio Wealth Limited Partnership held 84,811 shares of Thermo Fisher Scientific worth $52.5M as of Q3 2024.
  • Prio Wealth Limited Partnership sold 8,256 Thermo Fisher Scientific shares in Q3 2024, an estimated $4.89M.
  • Thermo Fisher Scientific made up 1.54% of Prio Wealth Limited Partnership's portfolio in Q3 2024, its #17 holding.
  • Prio Wealth Limited Partnership first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 46 quarters since.
  • Prio Wealth Limited Partnership's Thermo Fisher Scientific position peaked at $113M in Q4 2021.
  • 2,568 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on Prio Wealth Limited Partnership's 13F filing for Q3 2024, filed 21 Oct 2024.